<<返回上一页

Mixed results for Alzheimer's treatments

发布时间:2019-03-01 10:08:00来源:未知点击:

WHAT a strange week for Alzheimer’s disease. Rachelle Doody of Baylor College of Medicine in Houston, Texas, gave 120 patients Dimebon, an antihistamine drug, for a year. Their scores on practical cognitive ability tests rose significantly compared with those receiving a placebo, and their symptoms seemed to improve the longer they took the drug – a first for an Alzheimer’s drug (The Lancet, vol 372, p 207). Yet in the same issue (p 216), a team led by Clive Holmes of the University of Southampton, UK,